Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer

PACIFIC Investigators

Research output: Contribution to journalArticlepeer-review

1479 Citations (Scopus)

Fingerprint Dive into the research topics of 'Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences